[Side-effects and effects of lithium therapy on the endocrinium in man].
D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy*; D002395:Catecholamines / Q000378:metabolism; D003919:Diabetes Insipidus / Q000139:chemically induced; D005260:Female; D005755:Gastrins / Q000378:metabolism; D005934:Glucagon / Q000378:metabolism; D006042:Goiter / Q000139:chemically induced; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007037:Hypothyroidism / Q000139:chemically induced; D007455:Iodine / Q000378:metabolism; D007457:Iodine Radioisotopes; D008094:Lithium / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010179:Pancreas / Q000187:drug effects; D051381:Rats; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism; D013972:Thyrotropin / Q000032:analysis; D013974:Thyroxine / Q000032:analysis
D002395:Catecholamines; D005755:Gastrins; D007457:Iodine Radioisotopes; D013972:Thyrotropin; D005934:Glucagon; D007455:Iodine; D008094:Lithium; D013974:Thyroxine
Nebenwirkungen und Wirkungen der Lithiumtherapie beim Menschen im Bereich des Endokriniums.